ANALYSIS: With an Obermatt 360° View of 11 (better than 11% compared with alternatives), overall professional sentiment and financial characteristics for the stock Chunghwa Chemical Synthesis & Biotech are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Chunghwa Chemical Synthesis & Biotech. The consolidated Value Rank has a low rank of 22 which means that the share price of Chunghwa Chemical Synthesis & Biotech is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 78% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 1, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 1% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 45, which means that the company has a riskier financing structure than 55% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 6, which means that professional investors are more pessimistic about the stock than for 94% of alternative investment opportunities. ...read more